IGF-1 LR3 is a long-acting analogue of Insulin-Like Growth Factor-1, supplied as a high-purity, COA-verified research peptide. It is provided in lyophilised powder form for enhanced stability and is available in Australia for laboratory research use only.
IGF-1 LR3 has been widely studied in scientific research due to its extended half-life and increased resistance to binding proteins compared to native IGF-1, making it a useful tool in metabolic and cellular research models.
What IGF-1 LR3 Is Studied For
In laboratory and preclinical research settings, IGF-1 LR3 has been investigated for its role in:
Cellular growth and differentiation pathways
Protein synthesis and anabolic signalling mechanisms
Muscle cell development and regeneration models
Nutrient uptake and metabolic efficiency
Insulin-like signalling pathways
These effects are observed in research environments only and do not imply therapeutic or approved medical use.
Product Details
Form: Lyophilised powder
Purity: ≥ 99% (HPLC verified)
Verification: Certificate of Analysis (COA) provided
Structure: Modified IGF-1 analogue with extended activity
Grade: Research use only
Storage & Handling
Store at 2–8°C (refrigerated) or as specified on the COA
Protect from light and moisture
Avoid repeated freeze–thaw cycles
Handle using standard laboratory safety and aseptic procedures
Important Notice
This product is supplied strictly for laboratory research purposes.
Not for human or veterinary use.
Not intended to diagnose, treat, cure, or prevent any disease.
IGF-1 LR3 is a long-acting analogue of Insulin-Like Growth Factor-1, supplied as a high-purity, COA-verified research peptide. It is provided in lyophilised powder form for enhanced stability and is available in Australia for laboratory research use only.
IGF-1 LR3 has been widely studied in scientific research due to its extended half-life and increased resistance to binding proteins compared to native IGF-1, making it a useful tool in metabolic and cellular research models.
What IGF-1 LR3 Is Studied For
In laboratory and preclinical research settings, IGF-1 LR3 has been investigated for its role in:
Cellular growth and differentiation pathways
Protein synthesis and anabolic signalling mechanisms
Muscle cell development and regeneration models
Nutrient uptake and metabolic efficiency
Insulin-like signalling pathways
These effects are observed in research environments only and do not imply therapeutic or approved medical use.
Product Details
Form: Lyophilised powder
Purity: ≥ 99% (HPLC verified)
Verification: Certificate of Analysis (COA) provided
Structure: Modified IGF-1 analogue with extended activity
Grade: Research use only
Storage & Handling
Store at 2–8°C (refrigerated) or as specified on the COA
Protect from light and moisture
Avoid repeated freeze–thaw cycles
Handle using standard laboratory safety and aseptic procedures
Important Notice
This product is supplied strictly for laboratory research purposes.
Not for human or veterinary use.
Not intended to diagnose, treat, cure, or prevent any disease.